383 related articles for article (PubMed ID: 27501149)
1. Minnelide/Triptolide Impairs Mitochondrial Function by Regulating SIRT3 in P53-Dependent Manner in Non-Small Cell Lung Cancer.
Kumar A; Corey C; Scott I; Shiva S; D'Cunha J
PLoS One; 2016; 11(8):e0160783. PubMed ID: 27501149
[TBL] [Abstract][Full Text] [Related]
2. Triptolide induces mitochondria-mediated apoptosis of Burkitt's lymphoma cell via deacetylation of GSK-3β by increased SIRT3 expression.
Kong J; Wang L; Ren L; Yan Y; Cheng Y; Huang Z; Shen F
Toxicol Appl Pharmacol; 2018 Mar; 342():1-13. PubMed ID: 29407771
[TBL] [Abstract][Full Text] [Related]
3. SIRT3 deacetylates and promotes degradation of P53 in PTEN-defective non-small cell lung cancer.
Xiong Y; Wang L; Wang S; Wang M; Zhao J; Zhang Z; Li X; Jia L; Han Y
J Cancer Res Clin Oncol; 2018 Feb; 144(2):189-198. PubMed ID: 29103158
[TBL] [Abstract][Full Text] [Related]
4. Wild-type p53 reactivation by small-molecule Minnelide™ in human papillomavirus (HPV)-positive head and neck squamous cell carcinoma.
Caicedo-Granados E; Lin R; Fujisawa C; Yueh B; Sangwan V; Saluja A
Oral Oncol; 2014 Dec; 50(12):1149-56. PubMed ID: 25311433
[TBL] [Abstract][Full Text] [Related]
5. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
Hu Z; Zeng Q; Zhang B; Liu H; Wang W
Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
[TBL] [Abstract][Full Text] [Related]
6. A Newly Synthesized Rhamnoside Derivative Alleviates Alzheimer's Amyloid-
Li Y; Lu J; Cao X; Zhao H; Gao L; Xia P; Pei G
Oxid Med Cell Longev; 2020; 2020():7698560. PubMed ID: 32104538
[TBL] [Abstract][Full Text] [Related]
7. Sirtuin 3 induces apoptosis and necroptosis by regulating mutant p53 expression in small‑cell lung cancer.
Tang X; Li Y; Liu L; Guo R; Zhang P; Zhang Y; Zhang Y; Zhao J; Su J; Sun L; Liu Y
Oncol Rep; 2020 Feb; 43(2):591-600. PubMed ID: 31894331
[TBL] [Abstract][Full Text] [Related]
8. Minnelide: a novel therapeutic that promotes apoptosis in non-small cell lung carcinoma in vivo.
Rousalova I; Banerjee S; Sangwan V; Evenson K; McCauley JA; Kratzke R; Vickers SM; Saluja A; D'Cunha J
PLoS One; 2013; 8(10):e77411. PubMed ID: 24143232
[TBL] [Abstract][Full Text] [Related]
9. SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer's disease.
Lee J; Kim Y; Liu T; Hwang YJ; Hyeon SJ; Im H; Lee K; Alvarez VE; McKee AC; Um SJ; Hur M; Mook-Jung I; Kowall NW; Ryu H
Aging Cell; 2018 Feb; 17(1):. PubMed ID: 29130578
[TBL] [Abstract][Full Text] [Related]
10. Depletion of end-binding protein 1 (EB1) promotes apoptosis of human non-small-cell lung cancer cells via reactive oxygen species and Bax-mediated mitochondrial dysfunction.
Kim MJ; Yun HS; Hong EH; Lee SJ; Baek JH; Lee CW; Yim JH; Kim JS; Park JK; Um HD; Hwang SG
Cancer Lett; 2013 Oct; 339(1):15-24. PubMed ID: 23900080
[TBL] [Abstract][Full Text] [Related]
11. Sirt3 is a tumor suppressor in lung adenocarcinoma cells.
Xiao K; Jiang J; Wang W; Cao S; Zhu L; Zeng H; Ouyang R; Zhou R; Chen P
Oncol Rep; 2013 Sep; 30(3):1323-8. PubMed ID: 23842789
[TBL] [Abstract][Full Text] [Related]
12. The roles of endogenous reactive oxygen species and nitric oxide in triptolide-induced apoptotic cell death in macrophages.
Bao X; Cui J; Wu Y; Han X; Gao C; Hua Z; Shen P
J Mol Med (Berl); 2007 Jan; 85(1):85-98. PubMed ID: 17109129
[TBL] [Abstract][Full Text] [Related]
13. Triptolide induces apoptosis in human adrenal cancer NCI-H295 cells through a mitochondrial-dependent pathway.
Wu PP; Liu KC; Huang WW; Ma CY; Lin H; Yang JS; Chung JG
Oncol Rep; 2011 Feb; 25(2):551-7. PubMed ID: 21152873
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol regulates mitochondrial reactive oxygen species homeostasis through Sirt3 signaling pathway in human vascular endothelial cells.
Zhou X; Chen M; Zeng X; Yang J; Deng H; Yi L; Mi MT
Cell Death Dis; 2014 Dec; 5(12):e1576. PubMed ID: 25522270
[TBL] [Abstract][Full Text] [Related]
15. Triptolide alters mitochondrial functions.
Su Y; Yang S; Xiao Z; Wang W; Okunieff P; Zhang L
Adv Exp Med Biol; 2007; 599():139-46. PubMed ID: 17727258
[TBL] [Abstract][Full Text] [Related]
16. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
[TBL] [Abstract][Full Text] [Related]
17. Triptolide interrupts rRNA synthesis and induces the RPL23‑MDM2‑p53 pathway to repress lung cancer cells.
Wang J; Zhang ZQ; Li FQ; Chen JN; Gong X; Cao BB; Wang W
Oncol Rep; 2020 Jun; 43(6):1863-1874. PubMed ID: 32236588
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial inhibitor sensitizes non-small-cell lung carcinoma cells to TRAIL-induced apoptosis by reactive oxygen species and Bcl-X(L)/p53-mediated amplification mechanisms.
Shi YL; Feng S; Chen W; Hua ZC; Bian JJ; Yin W
Cell Death Dis; 2014 Dec; 5(12):e1579. PubMed ID: 25522273
[TBL] [Abstract][Full Text] [Related]
19. Sirt3 promotes hepatocellular carcinoma cells sensitivity to regorafenib through the acceleration of mitochondrial dysfunction.
Wang R; Liu Y; Mi X; Chen Q; Jiang P; Hou J; Lin Y; Li S; Ji B; Fang Y
Arch Biochem Biophys; 2020 Aug; 689():108415. PubMed ID: 32562663
[TBL] [Abstract][Full Text] [Related]
20. SIRT3 increases cisplatin sensitivity of small-cell lung cancer through apoptosis.
Guo R; Li Y; Xue Y; Chen Y; Li J; Deng X; Su J; Liu Y; Sun L
Gene; 2020 Jun; 745():144629. PubMed ID: 32229158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
